Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea · Delayed Price · Currency is KRW 3,940.00
+40.00 (1.03%)
At close: Nov 13, 2026
Genesystem Revenue
Genesystem had revenue of 432.34M KRW in the quarter ending June 30, 2026, with 523.04% growth. This brings the company's total for the last twelve months to 1.01B, down -4.59% year-over-year. In the year 2025, Genesystem had annual revenue of 381.36M, down -68.42%. That makes Genesystem the 44,027th largest company in the world by revenue and 2,595th in South Korea.
Revenue (ttm)
1.01B
Revenue Growth
-4.59%
P/S Ratio
31.99
Revenue / Employee
40.40M
Employees
25
Market Cap
32.65B
Revenue by Geography
- South Korea 207.75M 54.5%
- Asia 133.56M 35.0%
- Europe 39.30M 10.3%
- North America 751.00K 0.2%
Fiscal year ended Dec 31, 2025 See the full Genesystem breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 381.36M | -826.40M | -68.42% |
| Dec 31, 2024 | 1.21B | 310.73M | 34.64% |
| Dec 31, 2023 | 897.03M | -2.76B | -75.44% |
| Dec 31, 2022 | 3.65B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.